UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

25 Apr 2008

Neupro® recommended for approval in Europe for Restless Legs Syndrome

Read More
24 Apr 2008

UCB's CEO Confirms Company Strategy

Read More
22 Apr 2008

Cimzia® Approved in the US for the Treatment of Moderate to Severe Crohn's Disease

Read More
31 Mar 2008

Phase II results for CDP791 in non-small cell lung cancer support further clinical development

Read More
28 Mar 2008

New member of UCB's Board of Directors

Read More
20 Mar 2008

CHMP Upholds Negative Opinion for the EU Application for Cimzia® in the Treatment of Crohn's Disease

Read More

Stay up-to-date on the latest news and information from UCB